A vial labelled ”Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.
Dado Ruvic | Reuters
Novavax’s updated Covid vaccine won the backing of U.S. regulators on Tuesday, putting the shot on track to roll out weeks after new jabs from Pfizer and Moderna reached Americans.
The Food and Drug Administration authorized Novavax’s single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up.
The Centers for Disease Control and Prevention is now including Novavax’s shot in the same recommendation it issued last month for updated vaccines from Pfizer and Moderna. That recommendation says all Americans ages six months and older can receive an updated Covid jab.
Novavax said in a statement that doses of the shot will likely be available within the next few days.
“Novavax’s authorization today means people will now have the choice of a protein-based non-MRNA option to help protect themselves against Covid-19, which is now…
2023-10-03 15:49:20
Article from novavax-updated-covid-vaccine.html” target=”_blank” style=”color:blue” rel=”noopener”>www.cnbc.com